PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 683 (xsd:integer)
nif:isString
  • Given that 12-month VLS outcomes would be expected to differ by baseline treatment status/engagement, we created four mutually exclusive baseline treatment status groups: 1) newly diagnosed (in the 12 months prior to enrollment/pseudo-enrollment date), 2) consistently suppressed (≥2 VLs ≥90 days apart, and all VLs ≤200 copies/μL, in the 12 months prior to enrollment/pseudo-enrollment date), 3) consistently unsuppressed (all VLs reported >200 copies/μL or no VLs reported in the 12 months prior to enrollment/pseudo-enrollment), or 4) inconsistently suppressed (at least 1 VL ≤200 copies/μL, but not all VLs ≤200 copies/μL, in the 12 months prior to enrollment/pseudo-enrollment).
rdf:type